When managing suspected or proven Group A Streptococcus (GAS) Necrotizing Soft Tissue Infections (NSTIs), standard beta-lactams can lose efficacy due to the Eagle effect—where stationary-growth phase bacteria become less susceptible to cell-wall acting agents.
To counteract this and aggressively suppress life-threatening bacterial toxin production, always add a protein-synthesis inhibiting antibiotic to your empirical broad-spectrum base.
Clindamycin: Historically the gold standard for toxin suppression, shutting down the 50S ribosomal subunit. However, it is prone to frequent national supply shortages.
Linezolid: An increasingly preferred alternative that similarly binds the 50S ribosomal subunit for comparable toxin suppression. Linezolid provides both potent toxin suppression and excellent MRSA coverage. If you choose Linezolid, stop Vancomycin to avoid pharmacological redundancy.
References
Urbina, T., Razazi, K., Ourghanlian, C., Woerther, P.-L., Chosidow, O., Lepeule, R., & de Prost, N. (2021). Antibiotics in necrotizing soft tissue infections. Antibiotics, 10(9), 1104. https://doi.org/10.3390/antibiotics10091104
